First-Line Anti-Egfr Agents (Panitumumab or Cetuximab) Plus Chemotherapy in Patients With Metastatic Colorectal Cancer: Onco-Colon Turkey Study Subgroup Analysis

Isikdogan, A.Turk, H.Bilir, C.Sendur, M.Karabulut, B.Artac, M.Yalcin, S.2025-05-102025-05-1020220923-75341569-804110.1016/j.annonc.2022.04.180https://doi.org/10.1016/j.annonc.2022.04.180https://hdl.handle.net/20.500.14720/14241eninfo:eu-repo/semantics/openAccessFirst-Line Anti-Egfr Agents (Panitumumab or Cetuximab) Plus Chemotherapy in Patients With Metastatic Colorectal Cancer: Onco-Colon Turkey Study Subgroup AnalysisConference Object33Q1Q1S281S281WOS:000823826500103